HomeHealthcare & Life SciencesMedical Devices Premature Rupture Membranes Testing Market

Australia Premature Rupture Membranes Testing Market Size & Outlook, 2026-2034


Australia Premature Rupture Membranes Testing Market Insights

  • As per Reed Intelligence insights, the Australia Premature Rupture Membranes Testing Market stood at USD 6.3 Million in 2025 and is anticipated to grow to USD 13.55 Million by 2034.
  • The Australia market is expected to advance at a CAGR of 8.87% from 2026 through 2034.
  • In 2025, Immunoassay-Based Tests accounted for the highest share of the Type market size.
  • During the forecast period, Immunoassay-Based Tests is set to register the highest growth, making it the most lucrative Type segment.

Other Key Findings


  • In 2025, Australia accounted for 1.21% of the global Premature Rupture Membranes Testing Market size.
  • By 2034, United States is expected to lead the global Premature Rupture Membranes Testing Market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional Premature Rupture Membranes Testing Market size by 2034.
  • South East Asia is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 34.98 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 6.3 Million
Market Size In 2034 USD 13.55 Million
Largest segment Immunoassay-Based Tests
Units Revenue in USD Million
CAGR 8.87% (2026-2034)
Segmnetation Covered
Type
  1. Immunoassay-Based Tests
  2. Rapid Bedside Tests
Product
  1. Diagnostic Kits
  2. Instruments
Technology
  1. Conventional Methods
  2. Digital Automated Methods
End-Use
  1. Hospitals
  2. Diagnostic Clinics
  3. Others
Distribution Channel
  1. Direct Sales
  2. Distributors
  3. Online Channels
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports